Who owns Pharmacyclics?

Key details on Pharmacyclics (Ticker: PCYC)

Who owns Pharmacyclics?

Is PCYC a good stock to own? Find out who bought Pharmacyclics, who sold Pharmacyclics (PCYC) stock, and who holds a large position in Pharmacyclics.

Fund Name Number of Shares Share Valuation As Of
Baker Bros. Advisors 8.72M $922.32M Dec. 31, 2013
T. Rowe Price Associates 7.65M $808.77M Dec. 31, 2013
Vanguard 3.24M $343.04M Dec. 31, 2013
FMR 2.85M $301.66M Dec. 31, 2013
SUSQUEHANNA INTERNATIONAL 2.55M $269.71M Dec. 31, 2013
PRIMECAP Management Company 2.38M $251.83M Dec. 31, 2013
OrbiMed Advisors 2.18M $32.29M Dec. 31, 2011
Capital World Investors^ 1.96M $207.15M Dec. 31, 2013
BlackRock Institutional Trust Company, N.A. 1.74M $184.25M Dec. 31, 2013
STATE STREET CORPORATION 1.42M $81.98M Dec. 31, 2013
Columbus Circle Investors 1.36M $144.08M Dec. 31, 2013
GOLDMAN SACHS 1.04M $110.46M Dec. 31, 2013
S.A.C. Capital Advisors 939713 $99.40M Dec. 31, 2013
Barclays 895591 $94.04M Dec. 31, 2013
ALLIANCEBERNSTEIN 819502 $12.15M Dec. 31, 2011
Charles Schwab Bank 804100 $10.00M March 31, 2013
Visium Asset Management 758334 $60.98M March 31, 2013
Franklin Resources 755610 $60.05M June 30, 2013
Bridger Management 750000 $20.82M March 31, 2012
QVT Financial 672721 $54.09M March 31, 2013
NORTHERN TRUST 664810 $52.83M June 30, 2013
Janus Capital Management 643637 $68.08M Dec. 31, 2013
Ameriprise Financial 639535 $67.65M Dec. 31, 2013
BB Biotech AG 636542 $67.33M Dec. 31, 2013
Name Goodman & Company, Investment Counsel 593200 $46.67M June 30, 2013
Norges Bank Investment Management 592056 $62.63M Dec. 31, 2013

Who sold Pharmacyclics?

Fund Name Date Sold Number of Shares Sold Share Valuation
BVF Sept. 30, 2011 1.16M $13.70M
Sectoral Asset Management Sept. 30, 2011 745490 $8.82M
Jefferies Sept. 30, 2011 592862 $7.01M
Balyasny Asset Management March 31, 2011 1.75M $10.28M
Perceptive Advisors Dec. 31, 2010 2.81M $17.07M
Renaissance Technologies Dec. 31, 2010 890330 $5.41M